Hepatocellular carcinoma occurs frequently and early after treatment in HCV genotype 3 infected persons treated with DAA regimens

Hepatocellular carcinoma occurs frequently and early after treatment in HCV genotype 3 infected persons treated with DAA regimens

Abstract Background There are conflicting data regarding the risk of hepatocellular carcinoma (HCC) after direct-acting antiviral agent (DAA) treatment. Risk of HCC in HCV genotype-3 infected persons after DAA therapy is not well known. Methods We prospectively studied HCV infected persons initiated...

Full description

Bibliographic Details
Main Authors: Ghias Un Nabi Tayyab, Shafqat Rasool, Bilal Nasir, Ghazala Rubi, Abdul-Badi Abou-Samra, Adeel A. Butt
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Gastroenterology
Subjects:
Hepatocellular carcinoma
HCV genotype 3
DAA
Pakistan
Online Access:http://link.springer.com/article/10.1186/s12876-020-01249-4

Internet

http://link.springer.com/article/10.1186/s12876-020-01249-4

Similar Items